论文部分内容阅读
目的:中西医联合治疗对改善冠心病心衰患者生存质量的临床有效性研究。方法:抽取2014年5月-2015年5月期间我院收治的冠心病心衰患者68例,分为两组,对照组单纯采用西医治疗,研究组采用中西医联合治疗,分析两组治疗有效性。结果:治疗后,研究组LVEF、SF-36评分上升程度势,6min步行距离下降程度,与对照组比较有统计学的意义(P<0.05);且研究组临床总有效率91.18%,高于对照组73.53%,比较有统计学的意义(P<0.05)。结论:中西医联合治疗冠心病心衰的临床疗效较为显著,且能够进一步改善患者的生存质量,具有较高的临床应用价值。
Objective: To study the clinical efficacy of combined treatment of traditional Chinese and western medicine on improving the quality of life in patients with heart failure of coronary heart disease. Methods: Sixty-eight patients with coronary heart disease who were admitted to our hospital from May 2014 to May 2015 were divided into two groups. The control group was treated with Western medicine only. The study group was treated with combination of TCM and Western medicine, and the treatment effect of the two groups was analyzed Sex. Results: After treatment, the LVEF and SF-36 scores of the study group were increased, and the extent of the 6-minute walking distance was decreased, which was statistically significant compared with the control group (P <0.05). The total effective rate of the study group was 91.18% The control group 73.53%, more statistically significant (P <0.05). Conclusion: The clinical curative effect of combined treatment of traditional Chinese and western medicine on coronary heart disease is more significant, and can further improve the quality of life of patients with high clinical value.